Check Presentation to Dr. Tara O’Donohue at Memorial Sloan Kettering Cancer Center.
TeamConnor Childhood Cancer Foundation is excited to fund the pediatric cancer research grant to Dr. Tara O’Donohue at Memorial Sloan Kettering Cancer Center in New York for 2021. She will be conducting a clinical trial for pediatric patients with relapsed neuroblastoma. Neuroblastoma is an aggressive cancer in young children in which treatment is extensive and long-term survival is less than 50%. This trial will use a new investigational drug, carefully designed to avoid the ways in which cancer cells become resistant to treatment, and additionally to target secondary pathways that could slow the tumor’s growth. This phase I study will combine the new investigational drug with conventional chemotherapy, in attempts to improve the effectiveness of treatment and bolster patient’s responses.
We are very excited that the pediatric protocol evaluating repotrectinib in combination with irinotecan/temozolomide in pediatric patients with relapsed/refractory solid tumors is in the final stages of review by the IRB and will be submitted imminently to the FDA for final approval prior to opening the trial for accrual at our site. – Dr. Tara O’Donohue